BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35080293)

  • 1. New opportunities with biologic treatments in pediatric allergic and respiratory diseases.
    Tenero L; Piacentini G
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):8-10. PubMed ID: 35080293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in allergic and immunologic diseases: Promises and challenges in the era of personalized medicine.
    Desai M; Oppenheimer J
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):350-353. PubMed ID: 29421313
    [No Abstract]   [Full Text] [Related]  

  • 3. Uses of biologics in allergic diseases: What to choose and when.
    Saco TV; Pepper A; Casale TB
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):357-366. PubMed ID: 29499367
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for choosing a biologic for your patient with allergy or asthma.
    Saco T; Ugalde IC; Cardet JC; Casale TB
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):627-637. PubMed ID: 34642091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics.
    Dinakar C; Khan DA; Fineman SM; Lang DM; Tilles SA
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):354-356. PubMed ID: 29625663
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted Molecular Therapies in Allergy and Rhinology.
    Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics and biomarkers for asthma, urticaria, and nasal polyposis.
    Casale TB
    J Allergy Clin Immunol; 2017 May; 139(5):1411-1421. PubMed ID: 28477720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Biologics for Allergic Diseases.
    Wu AC; Fuhlbrigge AL; Robayo MA; Shaker M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1107-1117.e2. PubMed ID: 33069886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics for Asthma and Allergic Skin Diseases in Children.
    De Keyser HH; Chipps B; Dinakar C;
    Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34663682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Adverse Reactions to Biologics Used in Allergy-Immunology Practice.
    Chow TG; Oppenheimer J; Joshi SR
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3075-3086. PubMed ID: 36162800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation.
    L Ramos C; Namazy J
    Immunol Allergy Clin North Am; 2023 Feb; 43(1):187-197. PubMed ID: 36411004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis.
    Tosca MA; Olcese R; Girosi D; Casalini E; Scaglione M; Ciprandi G
    Allergol Immunopathol (Madr); 2023; 51(3):181-185. PubMed ID: 37169576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.
    Humbert M; Bousquet J; Bachert C; Palomares O; Pfister P; Kottakis I; Jaumont X; Thomsen SF; Papadopoulos NG
    J Allergy Clin Immunol Pract; 2019; 7(5):1418-1429. PubMed ID: 30928481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on biological therapies for pediatric allergic diseases.
    Castagnoli R; De Filippo M; Votto M; Marseglia A; Montagna L; Marseglia GL; Licari A
    Minerva Pediatr; 2020 Oct; 72(5):364-371. PubMed ID: 32686927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New biologics for allergic diseases.
    Manka LA; Wechsler ME
    Expert Rev Clin Immunol; 2018 Apr; 14(4):285-296. PubMed ID: 29611440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for treatment of refractory severe atopic dermatitis. A pediatric perspective.
    Iannelli M; Caminiti L; Vaccaro M; Marafioti I; Spinuzza A; Panasiti I; Barbalace A; Crisafulli G; Pajno GB
    Dermatol Ther; 2020 Jul; 33(4):e13519. PubMed ID: 32378300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
    Kaufman BP; Alexis AF
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Practical Guide to Using Biologics in Pediatric Dermatology.
    George A; Lansang RP; Lansang P; Gooderham M
    J Cutan Med Surg; 2024; 28(1):59-67. PubMed ID: 38229411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging biologics for the treatment of pediatric atopic dermatitis.
    Ghamrawi R; Bell KA; Balogh EA; Strowd LC; Feldman SR
    Expert Opin Biol Ther; 2020 Dec; 20(12):1435-1445. PubMed ID: 33078990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.